We can’t wait to see you this year as VEE kicks off, March 21-24 at the Javits Convention Center in downtown NYC. During VEE 2019, you’ll have the opportunity to obtain CE credits at events like the March Mania Imaging Track, learn techniques to improve your practice and get access to cutting-edge products and services, such as the ONLY true ultra-widefield retinal image, optomap. VEE also presents an excellent opportunity to network and socialize with eyecare experts and explore New York City, such as the ones that will be available in our booth, MS4849.
We encourage you to find out what’s new at Optos by pre-scheduling your demonstration or stop by our booth at your convenience. Since last year’s conference, we have continued to develop hardware and software platforms to offer new ways to enhance clinical exams.
If you have any questions about our UWF retinal imaging or our offerings at VEE, please call 1-800-854-3039 or email. We look forward to seeing you at the show!
In addition to AMD awareness, February has also been named Low Vision Awareness Month, a time to raise awareness about visual impairment and rehabilitation for those who are living with low vision.
What is Low Vision?
Low vision is the term used to describe significant visual impairment that can’t be corrected fully with glasses, contact lenses, medication or eye surgery, it includes:
Loss of best-corrected visual acuity to worse than 20/70 in the better eye. Significant visual field loss. Tunnel vision (lack of vision in the periphery) and blind spots are examples of visual field loss. Legal blindness. In the United States, legal blindness typically is defined as visual acuity of 20/200 or worse (in the better eye, with the best possible vision correction in place) or a field of view (visual field) that is constricted to 20 degrees or less.
Disability statistics from the 2014 American Community Survey show that 2.3 percent of individuals ages 16 and over have a visual disability or low vision.
Following are the definitions of visual acuity, according to the World Health Organization. These ratings are for vision in the better eye with the best possible prescription corrective lens:
Age-Related Macular Degeneration (AMD) is the leading cause of blindness among older Americans, but new treatments have dramatically changed the course of this disease over the last 10 years, making AMD more manageable than ever before. During AMD Awareness Month in February, the American Academy of Ophthalmology is reminding people that even though currently there is no cure for age-related macular degeneration, there are a number of things you can do to slow its effects and prevent blindness, early detection being a critical first step. AMD is the leading cause of irreversible vision loss in people over 50 and is rapidly growing, worldwide.
What is AMD? – AMD is a common eye condition and a leading cause of blindness in those 50 and older. Aging can cause the macula to slowly degenerate and reduce central vision. – AMD often advances so slowly that vision loss does not occur for many years and traces of the disease can go unnoticed. In others, the disease may progress faster and lead to vision loss in one or both eyes. Over time, objects in vision may not appear as bright as they once were and a blurred area in vision is common, further leading …
Jessica describes the events of that October 2017 day as somewhat serendipitous, even though what transpired illuminated a hidden threat to her life. Jessica, an actress, had just started rehearsing for a play in Billings, Montana, when she decided that contacts, rather than glasses, would better suit her part. “Really, I just thought it would be a good idea to be able to see while I was on stage,“ she laughs. “That’s all I needed was to get fitted for contacts. I didn’t feel that I needed, nor did I have time for, an eye exam. Besides I absolutely despise being dilated.” However, as fate would have it, she went that day to see Tom Felstet, OD, who feels strongly that a thorough view of the retina should be a part of every eye exam. Accordingly, Felstet had made it a priority to purchase an optomap ultra-widefield (UWF™) imaging device when he opened his new practice four years ago. He had the opportunity to utilize the technology during medical school and during his early years in practice. optomap is the only technology that captures over 80% of the retina in a single image, and it does so in a fraction …
Currently, there are more than 3 million people in the United States and over 60 million worldwide living with glaucoma, otherwise known as “the sneak thief of sight”. It is estimated that half of those with glaucoma, do not know they have it. The disease presents no symptoms and is the leading cause of irreversible blindness, taking as much as 40% of sight without notice. January has been deemed National Glaucoma Awareness Month and is an important time to spread the world about this sight-stealing disease.
What is Glaucoma?
Glaucoma is a group of eye diseases that gradually progress, stealing sight, without symptom. Glaucoma can affect people of all ages but is most prevalent in middle-aged adults and the elderly. While there is no cure, surgery or medication can slow its affects and help to prevent further vision loss. The word ‘glaucoma’ is actually an umbrella term for a group of eye diseases that damage the delicate fibers that run from your eye to your optic nerve, which is the nerve that carries information about the images your eye sees to your brain. This damage is often the result of high fluid pressure inside the eye.
What can you do?